Esketamine Combined With Pregabalin on CPSP in Spinal Patients.

PHASE2/PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

November 10, 2023

Primary Completion Date

May 31, 2024

Study Completion Date

June 30, 2024

Conditions
EsketaminePregabalineChronic Post Operative Pain
Interventions
DRUG

S-ketamine and pregabalin

"* Drug: Pregabalin~* 150mg (2hrs) pre operatively and 75mg twice daily post operatively for 7 days(POD1-7), followed by dose reduction to 75mg once daily for 7 days(POD8-14)~* Drug: S-ketamine infusion~* 0.5 mg/kg bolus after induction of anesthesia +0.12 mg/kg/h continuous intravenous infusion for 48 h"

DRUG

Normal saline and placebo capsule

"* Drug: Placebo capsules~* Two placebo capsules (2hrs) preoperatively and twice daily post operatively for 7days, followed by dose reduction to single capsule once daily for 7days~* Drug: Normal saline~* 0.9% saline bolus after induction of anesthesia + intravenous infusion for 48 hours"

Trial Locations (1)

100070

Beijing Tiantan Hospital, Beijing

All Listed Sponsors
lead

Beijing Tiantan Hospital

OTHER

NCT06117917 - Esketamine Combined With Pregabalin on CPSP in Spinal Patients. | Biotech Hunter | Biotech Hunter